# Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients

> **NCT01271478** · PHASE4 · COMPLETED · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 60 (actual)

## Conditions studied

- Inflammation
- End-stage Renal Disease

## Interventions

- **DRUG:** captopril plus placebo
- **DRUG:** telmisartan plus placebo
- **DRUG:** Telmisartan plus Captopril
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01271478
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-12
- **Final completion:** 2013-08-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01271478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01271478, "Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01271478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*